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Innate immune evasionThe objective of this study was to identify porcine reproductive and respiratory syndrome virus (PRRSV)-
encoded proteins that are responsible for the inhibition of TNF-α expression and the mechanism(s) involved
in this phenomenon. Using a TNF-α promoter reporter system, the non-structural protein 1 (Nsp1) was
found to strongly suppress the TNF-α promoter activity. Such inhibition takes place especially at the
promoter's proximal region. Both Nsp1α and Nsp1β, the two proteolytic fragments of Nsp1, were shown to
be involved in TNF-α promoter suppression. Furthermore, using reporter plasmids speciﬁc for transcription
factors (TFs) that bind to TNF-α promoter, Nsp1α and Nsp1βwere demonstrated to inhibit the activity of the
TFs that bind CRE-κB3 and Sp1 elements respectively. Subsequent analyses showed that Nsp1α moderately
inhibits NF-κB activation and that Nsp1β completely abrogates the Sp1 transactivation. These ﬁndings reveal
one of the important mechanisms underlying the innate immune evasion by PRRSV during infection.sity of Nebraska-Lincoln,
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Porcine reproductive and respiratory syndrome is an economically
important disease causing losses to swine industry worldwide. The
disease is characterized by late term reproductive failure in sows and
respiratory distress in young growing pigs (Wensvoort, 1993). The
severity of the disease in young pigs is related to the age and the
multi-factorial nature of the disease. The disease is caused by an
arterivirus, porcine reproductive and respiratory syndrome virus
(PRRSV) that belongs to the order, Nidovirales. PRRSV is a single
stranded, positive sense RNA virus having a genome of approximately
15 kb in size (Meulenberg et al., 1993). PRRSV predominantly
replicates in differentiated cells of myeloid lineage such as macro-
phages and dendritic cells (Duan et al., 1997; Wang et al., 2007;
Wensvoort, 1993). Since macrophages and dendritic cells are major
producers of innate defensive cytokines such as interferon-alpha
(IFN-α) and tumor necrosis factor-alpha (TNF-α) during viral
infections, it seems plausible that PRRSV may actively suppress their
induction in order to replicate in the host cells for multiple rounds and
fulﬁll the pathogenic goal of establishing persistency in the host
(Allende et al., 2000; Beura et al., 2009; Lopez-Fuertes et al., 2000). In
addition, the defective induction of innate immune defense againstPRRSV may contribute to the delayed and weak development of
antigen speciﬁc adaptive immune responses later during PRRSV
infection (Lopez and Osorio, 2004; Meier et al., 2003). PRRSV encodes
8 open reading frames that produce 14 non-structural proteins (Nsps)
and 7 structural proteins. Recent studies from our laboratory have
shown that several proteins such as Nsp1, Nsp2, Nsp4, and Nsp11 are
able to suppress IFN-β promoter activation upon dsRNA treatment
(Beura et al., 2009). These proteins suppress the induction of Type I
IFNs and signaling by inhibiting transcription factors such as
interferon regulatory factor-3, nuclear factor-κB, CREB-binding pro-
tein (CBP) and signal transducers and activators of transcription-1
(STAT-1) (Beura et al., 2009; Chen et al., 2009; Kim et al., 2010).
However, the molecular mechanisms underlying the TNF-α suppres-
sion by PRRSV are unknown.
TNF-α is an immediate-early cytokine, which is secreted in
response to various viral infections by activated macrophages,
dendritic cells and T cells. TNF-α has two biological functions: First,
it induces apoptosis in virus infected cells. This effect of TNF-α on
virus infected cells is synergistically augmented by the presence of
IFN-γ (Wong and Goeddel, 1986). Second, TNF-α promotes inﬂam-
mation at the site of infection by inducing the production of other
proinﬂammatory cytokines at the vicinity of infection (Toews, 2001).
TNF-α directly inhibits replication of both DNA and RNA viruses in
vitro (Cirino et al., 1993; Heise and Virgin, 1995; Wong and Goeddel,
1986). Viruses such as African swine fever virus (ASFV) and herpes
simplex virus-1 (HSV-1) directly inhibit induction of TNF-α during
Fig. 1. PRRSV down modulates TNF-α response during in vitro infection in PBMC derived
macrophages. (A) Quantitative PCR analysis of TNF-αmRNA levels in PRRSV infected and
LPS stimulated cells. PBMC derived macrophages were either mock infected or infected
with PRRSV (FL12 strain) at amultiplicity of infection of 10. LPS stimulated cellswere used
as positive control for TNF-α response in these cells. Cells were collected at indicated time
points after infection. RNAs were isolated from these cells and cDNAs were prepared and
subjected to quantiﬁcation by quantitative PCR. The TNF-α mRNA copy numbers were
normalized with that of endogenous β-actin mRNA copy numbers. Bars represent the
average of TNF-αmRNA copynumbers relative to that inmock control±standard error of
mean (SEM) from three independent experiments done with cells collected from three
different pigs. (B) Measurement of TNF-α protein levels in the supernatant of same
treatments mentioned in panel A. Supernatants were collected and the TNF-α protein
levels were measured by using a commercial swine TNF-α speciﬁc ELISA. Bars represent
the average amount of TNF-α (in picograms (pg)/mL±SEM. (C) Viral titers in the
supernatants of same treatments mentioned in panel A, to check for kinetics of viral
replication. Viral titers were measured in MARC-145 cells and expressed as tissue culture
infectious dose50/mL. Error bars represent the SEM.
271S. Subramaniam et al. / Virology 406 (2010) 270–279infection (Granja et al., 2006; Mogensen et al., 2004). Several studies
have shown that PRRSV is also able to suppress the TNF-α production
both in vitro and in vivo. (Lopez-Fuertes et al., 2000; Thanawongnu-
wech et al., 2004; Van Gucht et al., 2003; Van Reeth et al., 1999).
The objective of the present study was to identify the PRRS viral
proteins that inhibit TNF-α expression, especially at the promoter
level, and determine the underlying mechanism(s) through which
this virus inhibits TNF-α production. Among 11 PRRSV encoded
proteins screened, only Nsp1 was able to strongly suppress the TNF-α
promoter. Moreover, both Nsp1α and Nsp1β, products of Nsp1
derived by auto-cleavage process, were involved in the TNF-α
promoter suppression. Further detailed analyses showed that Nsp1α
and Nsp1β inhibit TNF-α promoter by inhibiting NF-κB activation and
Sp1 transactivation, respectively. These ﬁndings provide a mechanis-
tic understanding of how PRRSV utilizes two of its non-structural
proteins to suppress the TNF-α promoter activation. This study also
gives insights into how PRRSV evades the immune response by
inhibiting innate immune defenses during infection.
Results
PRRSV inhibits TNF-α production in infected swine macrophages
Previous studies have shown that PRRSV induces a weak TNF-α
response during in vitro and in vivo infection (Lopez-Fuertes et al., 2000;
Van Reeth et al., 1999). In order to reconﬁrm the defective TNF-α
response during PRRSV infection in our own experimental system,
macrophages were derived in vitro from peripheral blood mononuclear
cells (PBMCs) as described inMaterials andmethods. The phenotype of
these macrophages was characterized by the expression of various
surface markers and was found to be SWC3+MHCII+CD163+. These
cellswere found to bepermissive for PRRSV to a level comparable to that
exhibited by pulmonary alveolarmacrophages, the natural host cells for
PRRSV in vivo (data not shown). These PBMC-derived macrophages
were infected with a highly virulent PRRSV strain derived from an
infectious clone, FL12 (Kwon et al., 2006a,b; Truong et al., 2004) at a
multiplicity of infection of 10. LPS-stimulated cells and mock infected
cellswere used as positive and background controls for TNF-α response,
respectively. When TNF-αmRNA levels weremeasured by quantitative
PCR, therewere no detectable TNF-αmRNA levels during 2 and 6 h post
PRRSV infection (PI), when compared to LPS stimulated cells (Fig. 1A).
However, signiﬁcant levels of induction of TNF-αmRNAwere observed
at 12 and 24 h PI. Even though there was a delayed TNF-α
transcriptional response observed during PRRSV infection, there were
no detectable levels of secreted TNF-α protein in the supernatant of
infected macrophages as determined by ELISA (Fig. 1B). The kinetics of
PRRSV infection in the infectedmacrophages wasmeasured by titrating
virus contained in the supernatant of infected cells, which showed peak
viral titers at 12 h PI (Fig. 1C). Hence, PRRSV induces a delayed TNF-α
transcriptional response,which coincideswithpeak viral replication but
fails to elicit TNF-α protein secretion at any timepoints observed during
in vitro infection in PBMC derived macrophages.
PRRSV Nsp1α and Nsp1β suppress activation of the proximal region of
swine TNF-α promoter
ASFV A238L protein inhibits TNF-α production by modulating the
activity of transcription factors at the promoter level (Granja et al.,
2006). In the current study with PRRSV, we examined which PRRSV
proteins are involved in the down-regulation of TNF-α expression at
the promoter level. To that end, a swine TNF-α promoter-based
luciferase reporter plasmid was constructed and used to screen
various PRRSV non-structural proteins and the N protein for
suppression of the reporter activity in transfected RAW 264.7 cells.
We used lipopolysaccharide (LPS), a known inducer of TNF-α, to
activate swine TNF-α promoter. Upon LPS stimulation, of all thePRRSV proteins tested, only Nsp 1 was able to strongly and
signiﬁcantly suppress the full length swine TNF-α promoter activa-
tion (Fig. 2A). Previous reports suggested that the proximal region of
Fig. 2. Two non-structural proteins down modulate the activity of TNF-α promoter at its proximal region. (A) Screening among different proteins of PRRSV to ﬁnd the proteins that
inhibit TNF-α promoter activity. RAW264.7 cells were transfected with pswTNF-luc plasmid (0.2 μg) along with different PRRS viral protein expressing plasmids (1 μg) and a renilla
luciferase vector (10 ng). Transfected cells were incubated for 24 h and stimulated with LPS (1 μg/mL) for 6 h. Fireﬂy luciferase activities in cell lysates were measured which were
normalized with the renilla luciferase activities. (B) Effect of Nsp1 on proximal region of TNF-α promoter. RAW 264.7 cells were transfected with a luciferase construct under the
control of proximal region (−194) of TNF-α promoter (0.2 μg) along with Nsp1 expressing plasmid (1 μg) and a renilla luciferase vector (10 ng). Cells were stimulated and luciferase
activities were measured as described in previous panel. (C) Role of Nsp1α and Nsp1β in mediating TNF-α promoter suppression. TNF-α speciﬁc luciferase assays were done as
explained earlier using plasmids that express Nsp1α and Nsp1β separately. Bars in ﬁgures of all panels represent the average of luciferase units relative to unstimulated cells±SEM.
Data in ﬁgures of all panels were calculated from values from three independent experiments. For all the cases, a p-value of less than 0.05was considered signiﬁcant (unpaired t test),
CV: control vector.
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promoter (Haudek et al., 1998; Yao et al., 1997). Hence, the effect of
Nsp1 on the proximal region (−194) of TNF-α promoter was next
examined. As shown in Fig. 2B, Nsp1 was able to strongly suppress the
proximal region (−194) of swine TNF-α promoter in transfected cells.
This indicates that Nsp1's suppressive activity on TNF-α promoter
resides on the proximal region of the promoter.
PRRSV Nsp1 is auto-cleaved into two separate proteins, Nsp1α and
Nsp1β in infected cells (Chen et al., 2009; Den Boon et al., 1995).
Recently, the exact cleavage site between Nsp1α and Nsp1β has been
determined (Chen et al., 2009; Sun et al., 2009). In order to ﬁnd the
role of these cleaved products in TNF-α promoter suppression, their
respective coding regions were cloned separately in frame with a Nterminal Flag tag under CMV promoter. As shown in Fig. 2C, both
Nsp1α and Nsp1β equally suppress the TNF-α promoter but not to the
levels of the whole Nsp1 protein. In summary, PRRSV Nsp1 and its
cleaved products may target cellular transcriptional factors that bind
to the proximal region of TNF-α promoter and consequently suppress
the promoter activation. Both subunits of Nsp1 are collaboratively
involved in this TNF-α promoter suppression.
Effect of PRRSV Nsp1α and Nsp1β on different transcription factors that
bind to TNF-α promoter
Different transcription factors are known to bind TNF-α promoter
especially at −192 proximal region of the promoter and form a
Fig. 3. Transcription factors affected by Nsp1α and Nsp1β at the proximal region (−194) of TNF-α promoter. (A) Pair wise sequence alignment of swine TNF-α promoter sequence
(lower row) with that of human sequence (upper row). The nucleotides in the human sequence that are conserved with that in swine sequence are denoted by dots. Gaps in the
sequences are denoted by dashes. Predicted functional elements that bind to transcription factors are in bold and underlined. The names of the cis-acting functional elements or
binding transcription factors are indicated above the sequence. Number represents the position of nucleotide relative to transcription start site of human sequence. TBP : TATA
binding protein. The transcription start sites of respective sequences were denoted by ts (+1 position). The ts of human was considered for all cases in this study. (B) Schematic
diagram that shows the sequences and the repeats of cis-acting TFs speciﬁc elements that were cloned upstream of a basal TATA promoter in a luciferase construct. The sequences of
functional elements are depicted above the schematic diagrams of the constructs and are denoted in bold as well as underlined. (C) Effect of Nsp1 and its autocleaved products on the
activity of different transcription cis-acting functional elements at TNF-α promoter. RAW264.7 cells were transfected with each TF(s) speciﬁc reporter construct (0.2 μg) along with
plasmids expressing Nsp1 or its autocleaved products (1 μg) and renilla luciferase vector (10 ng). After 24 h post-transfection, cells were stimulated with LPS and luciferase activities
weremeasured as described earlier. For non-speciﬁc luciferase activities, a Gal4 speciﬁc reporter construct was employed. Data represent the average of relative luciferase units from
three independent experiments±SEM. A p-value of less than 0.05 was considered as statistically signiﬁcant (unpaired t test). CV: Control vector.
273S. Subramaniam et al. / Virology 406 (2010) 270–279
274 S. Subramaniam et al. / Virology 406 (2010) 270–279speciﬁc transcriptional complex upon activation by various stimuli
(Falvo et al., 2000; Tsai et al., 2000). The pair-wise sequence
alignment comparison of human and swine TNF-α proximal promoter
sequences (Fig. 3A) shows that the transcription factor binding sites
(except Sp1/Egr1 binding site) seem to be well conserved between
human and swine. With the aim of ﬁnding the transcription factors
affected by Nsp1α and Nsp1β, luciferase reporter plasmids speciﬁc for
different functional transcription factors were constructed by utilizing
speciﬁc sequences derived from swine TNF-α promoter (Fig. 3B). In
addition, Gal4, a yeast transcription factor speciﬁc reporter plasmid
was constructed to use as non-speciﬁc response control in the assay.
As shown in Fig. 3C, Nsp1α was able to signiﬁcantly suppress the
activity of transcription factors at CRE-κB3. It was also found to weakly
suppress the activity of transcription factors that bind to the Egr1/Sp1
element. However, in contrast to Nsp1α, Nsp1β suppresses the
activation of a different transcription factor (Sp1) especially at the
proximal site of the TNF-α promoter (Fig. 3B). Nsp1β also strongly
suppresses the transcription factors that bind to Egr1/Sp1 element
(Fig. 3B). In conclusion, Nsp1α partially inhibits the transcription
factors that bind to CRE-κB3. Nsp1β strongly inhibits the activity of
Sp1 at both sites in the TNF-α promoter.
PRRSV Nsp1α partially inhibits NF-κB activation
Nsp1α is able to suppress the transcription factors that bind CRE-
κB3 element of TNF-α promoter (Fig. 3C). ATF2/c-jun and p65/p50
complexes are known to directly interact with CRE and κB3 sites,
respectively (Tsai et al., 2000). Many viruses such as human
immunodeﬁciency virus and poxviruses are known to encode
proteins that modulate NF-κB activation during infection (Bour
et al., 2001; Nichols and Shisler, 2009). Hence, the effect of Nsp1α
on NF-κB activation was next examined. To this end, using a reporter
plasmid speciﬁc for NF-κB activation, Nsp1α was found to partially
suppress the NF-κB activation in transfected cells upon LPS stimula-
tion (Fig. 4). Hence, the Nsp1αmediates an inhibitory effect on NF-κB
activation to suppress the activation of TNF-α promoter.
PRRSV Nsp1β strongly inhibits transactivation of Sp1 especially through
its B domain
Nsp1β was found to inhibit the reporter activity speciﬁc to
endogenous Sp1 upon LPS stimulation (Fig. 3C). Consistently, Sp1 isFig. 4. Nsp1α inhibits NF-κB activation. (A) RAW 264.7 cells were transfected with
pGL4.32NF-κBRE-luc (0.2 μg) along with plasmids expressing either Nsp1 or Nsp1α
(1 μg) and renilla luciferase vector (10 ng). Cells were stimulated with LPS and
luciferase activities weremeasured from cell lysates as described earlier. Data represent
the average of relative luciferase units from three independent experiments±SEM. A
p-value of less than 0.05 was considered as statistically signiﬁcant (unpaired t test).
CV: Control vector.recruited to TNF-α promoter in an inducible manner during virus
infections in different cell types (Falvo et al., 2000). Since Sp1 is a
transactivator at many inducible promoter activations (Wierstra,
2008), we examined whether Nsp1β affects the transactivation
potential of Sp1. The n-terminal sequences (1–615 amino acids
position) of Sp1 were found to mainly contribute to the transactiva-
tion potential of Sp1 (Wierstra, 2008). To that end, it was fused in
frame with DNA binding domain of Gal4, a yeast transcription factor
to construct Gal4-Sp1 fusion protein (Fig. 5A). This Gal4-Sp1 fusion
protein can bind Gal4 responsive element containing promoter to
stimulate the reporter activity in transfected cells upon LPS
stimulation. This reporter activity is then directly proportional to
the transactivation potential of Sp1 n-terminal region fused to Gal4
DNA binding domain. As shown in Fig. 5B, Nsp1β was able to
completely suppress the transactivation of Sp1 upon LPS stimulation.
The transactivation potential of Sp1 is mainly carried out by A and
B domains of Sp1, each of which contains a glutamine-rich domain
(Wierstra, 2008). In addition, Sp1 has a negative inhibitory domain at
its n-terminus which can repress the transactivation mediated
through other domains, such as A and B domains, by recruiting
repressors and co-repressors to Sp1 (Lee et al., 2005; Murata et al.,
1994). During activation, this negative inhibitory domain is removed
by ubiquitin-dependent proteasomal activity (Spengler and Brattain,
2006). Complete removal of this negative regulatory domain from Sp1
transactivation region did increase the transactivation ability of Sp1
but did not have any effect on the ability of Nsp1β to suppress the
activity of Sp1 (Fig. 5C). Hence, n-terminal negative inhibitory domain
of Sp1 has no role in Nsp1βmediated inhibition of Sp1 transactivation.
LPS was found to activate transactivation of Sp1 mainly through its B
domain rather than A domain (Brightbill et al., 2000). Gal4 fusion
protein with only B domain of Sp1 has transactivation ability
comparable to that of the whole transactivation region without N
domain (Fig. 5C and D). Moreover, it was known that glutamine-rich
c-terminal region of Sp1 B domain (Sp1Bc) was found to be sufﬁcient
for activation of Sp1 dependent promoter (Gill et al., 1994). Hence, we
investigated whether Nsp1β was able to suppress the B domain
especially through its glutamine-rich c-terminal region. As shown in
Fig. 5D, Nsp1βwas able to strongly suppress the transactivation of Sp1
B domain as well as its glutamine rich c-terminal region. Overall,
Nsp1β seems to inhibit the TNF-α promoter by suppressing the
transactivation of Sp1 probably by modulating the interactions of
glutamine-rich region of Sp1 B domain.
Discussion
Porcine reproductive and respiratory syndrome virus replicates in
macrophages and dendritic cells and suppresses innate cytokines such
as Type I interferons and TNF-α (Beura et al., 2009; Chen et al., 2009;
Kim et al., 2010; Lopez-Fuertes et al., 2000). In this paper, we
identiﬁed the PRRS viral protein-Nsp1 that mediates such suppression
at the level of the promoter of TNF-α. Moreover, we found that both
constitutive subunits of Nsp1 (Nsp1α and Nsp1β) suppress the TNF-α
promoter by modulating activities of transcription factors NF-κB and
Sp1, respectively. Our data also suggest that by inhibiting transcrip-
tion factors activated by two important pathways, NF-κB pathway and
MAPK pathway, PRRSV can effectively inhibit the TNF-α promoter to
suppress TNF-α mediated apoptosis of infected cells.
In our experiments, PRRSV induced negligible levels of TNF-α
during in vitro infection of PBMC-derived macrophages. Particularly,
there was a failure of induction of TNF-α mRNA during PRRSV
infection at early time points after infection, which would suggest
that, at the MOI used, the genomic RNAs of input virus may not
activate TNF-α gene. However, there is an up regulation of TNF-α
mRNA levels observed at later time points of PRRSV infection.
Moreover, there may be an involvement of a post-transcriptional
mechanism used by PRRSV to suppress TNF-α production either at
Fig. 5.Nsp1β suppresses the transactivation of Sp1. (A) Schematic diagram that shows the sequences of Sp1 (black box) cloned in framewith Gal4 DNA binding domain (DBD, 1–147
aminoacids position, grey box). The letters above Sp1 TAD (black box) indicate the position of Sp1 domains in the transactivation region. The number below each construct indicates
the position of aminoacids in Sp1 sequence. (B) Effect of Nsp1β on transactivation potential of Sp1. RAW264.7 cells were transfected with pGal4RE-luc (1 μg), plasmids expressing
Nsp1 or Nsp1β, pCDNA3.1 vector expressing Gal4-Sp1TAD fusion protein (1 μg) and renilla luciferase vector (10 ng). Cells were stimulated with LPS and luciferase activities were
measured as described earlier. (C and D) Effect of Nsp1β on the activity of n-terminal negative inhibitory domain (N domain) (C) or internal transactivating B domain (D) of Sp1.
Transactivation assay was done as described earlier (5B) except that pCDNA3.1 vector expressing Gal4 fusion proteins that lack 1–90 aminoacids of Sp1 (N domain) , that have either
whole B domain (263–542 aminoacids position) or c-terminal of B domain (421–542 aminoacids position) of Sp1 were used to transactivate Gal4RE promoter of luciferase construct.
Data in all of above experiments are the averages of values from three independent experiments±SEM. A p-value of less than 0.05 was considered as statistically signiﬁcant
(unpaired t test). CV: Control vector.
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mRNAs at later phases of infection, the secreted levels of TNF-α were
not detected. Our results were consistent with previous publications
reporting that, apart from inducing anti-apoptotic transcripts, PRRSV
does not up regulate TNF-α production during in vitro as well as in
vivo infection (Genini et al., 2008; Thanawongnuwech et al., 2004;
Van Gucht et al., 2003; Van Reeth et al., 1999). Lopez-Fuertes et al.
(2000) reported that PRRSV elicits a defective transcriptional
response during early hours of infection with no protein secreted at
any time points after infection.
In order to ﬁnd the proteins that may have inhibitory effect on
TNF-α promoter, several non-structural proteins and N protein of
PRRSV were screened using a swine TNF-α promoter based luciferase
reporter assay. LPS was used as a stimulant for TNF-α transcription in
the luciferase assay to mimic TLR mediated induction of TNF-α byvirus (Takeda and Akira, 2005). Only Nsp1 was found to be actively
suppressing the swine TNF-α promoter. Hence, in addition to anti-IFN
activities (Beura et al., 2009), Nsp1 also has an anti-TNF activity.
Moreover, regarding Nsp1 mediated suppression, there was no
difference observed between a full length TNF-α promoter and a
region of TNF-α promoter involving 194 nucleotides proximal to
transcriptional start site. This proximal region of TNF-α promoter had
been previously demonstrated to be sufﬁcient for optimal stimulation
of TNF-α promoter (Panne et al., 2007; Yao et al., 1997). Like in the
case of anti-IFN activities, both of the auto-cleaved subunits of Nsp1,
Nsp1α and Nsp1β, were involved in the suppression of the TNF-α
production. Whole length Nsp1 suppresses TNF-α promoter stronger
than Nsp1α or Nsp1β do. Hence, it is conceivable that a synergistic
functional interaction may exist between these two Nsp1 subunits to
strongly suppress TNF-α promoter by targeting activities at the
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two Nsp1 subunits are synthesized at the earliest times following
PRRSV infection as they may have been selected evolutionarily to
inhibit innate cytokines such as TNF-α and type I interferons. Hence,
in addition to its role in replication, transcription and virion
biogenesis (Beura et al., 2009; Chen et al., 2009; Kim et al., 2010;
Nedialkova et al., 2010; Tijms et al., 2007), the multi-functional
protein Nsp1 has anti-innate immunity roles that could facilitate viral
replication in antigen presenting cells , such as macrophages. This
negative effect on innate immunity may play a key role in dampening
subsequent adaptive immune responses during PRRSV infection.
Both Nsp1α and Nsp1β suppresses functional activities of different
regions of the TNF-α promoter such as CRE-κB3 and Sp1 elements in
the proximal region of the TNF-α promoter respectively (Fig. 6).
Hence, both these proteins may target some transcription factors that
bind to these elements, which are strictly essential for TNF-α
transcription regardless of the type of stimuli or cell type (Falvo
et al., 2000; Tsai et al., 2000). In that regard, Nsp1α was found to
partially inhibit the activity of NF-κB in reporter assay which employs
tandem NF-κB binding sites. Therefore, it is speculated that the
Nsp1α-mediated inhibition of NF-κB at κB3may prevent the assembly
of ATF2-c-jun-NF-κB complex at CRE-κB3 site and further recruitment
of CBP or p300 to TNF-α promoter (Gerritsen et al., 1997; Kawasaki
et al., 1998). A previous study also shows that mutation in either CRE
or κB3 element completely abrogates the functionality of CRE-κB3 site
in the context of TNF-α promoter (Yao et al., 1997).
In contrast to Nsp1α, Nsp1β suppresses a different transcription
factor (Sp1) both at proximal and distal Sp1 binding sites. Nsp1β does
inhibit the transactivation of Sp1, mediated through glutamine-rich
region of its B domain that was demonstrated to be primarily involved
in the LPS mediated Sp1 transactivation (Brightbill et al., 2000).
Consequently, Nsp1βmay be involved in the inhibition of interactions
of glutamine-rich region of Sp1 B domain with RNA polymerase
initiator complex (TFIID) at proximal Sp1 binding site in TNF-α
promoter and suppresses the transcription. The glutamine rich c-
terminal region of Sp1 B domain (Sp1Bc) is sufﬁciently able to interact
with basal transcriptional machinery especially through direct
interactions with transcription initiation factor TFIID subunit 4
(Taf4) and TATA binding protein (TBP) to recruit the RNA polymerase
initiation complex to the promoter in a speciﬁc manner (Emili et al.,
1994; Gill et al., 1994). In addition to the suppression of Sp1 at
proximal binding site, Nsp1β also strongly suppresses the transcrip-
tion factors that bind to distal Egr1/Sp1 element. This may be
explained by the fact that Egr1 and Sp1, both of which bind to this
element, would be reciprocally regulating the activity of each otherFig. 6. Schematic diagram of the mechanisms behind PRRSV mediated suppression of TNF-α
promoter. Nsp1α also has weak inhibitory effect at distal Sp1/Egr1 overlapping site of TNF-α
and distal binding sites of TNF-α promoter. The number denotes the position of transcript
adapted with little modiﬁcations from a previous study about TNF-α promoter regulation ((Ruo-Pan Huang et al., 1997). Consequently, by inhibiting Sp1, Nsp1β
would also control the activity of Egr-1at this element.
Moreover, based on our studies, Nsp1β of PRRSV would be one of
the rare examples of viral proteins of a RNAvirus capable ofmodulating
the inducible activity of Sp1 and inhibiting a Sp1-dependent gene i.e.
TNF-α. Only one other viral protein, HIV tat was shown to bind and
modulate the activities of Sp1 (Howcroft et al., 1995). Interestingly,
Sp1 is also involved in the expression of several immunomodulatory
genes such asMHCClass I Chain-Related ProteinA (MICA), interleukin-
12 p35 subunit, etc. (Andresen et al., 2007; Goriely et al., 2003).
Therefore, the possible role of Nsp1β in the regulation of other Sp1
dependent genes during PRRSV infection would be of further interest.
The logical extension of this research is to ﬁne map Nsp1
sequences that are involved in TNF-α suppression. Using a reverse
genetics approach, mutant viruses that relieve TNF-α suppression
could be generated bymutating the sequences that normally suppress
TNF-α in the context of PRRSV-FL12 full length infectious clone. Such
enhanced TNF-α production could be anticipated to limit PRRS viral
replication in susceptible cells in vivo thereby reducing viremia and
pathogenicity. In addition, the virus-induced TNF-α is expected to
improve antiviral adaptive immune responses especially by inducing
other immunoregulatory cytokines such as IL-8, IL-6, IL-1, thus
potentially making such mutant PRRSV interesting as a putative live
attenuated virus vaccine candidate.
Materials and methods
Cell lines and viruses
RAW264.7, a murine macrophage cell line (obtained from ATCC)
was maintained in RPMI-1640 with 25 mM HEPES (Mediatech)
supplemented with 10% fetal bovine serum (FBS). MARC-145 cells
(obtained from Dr. Will Laegrid, USMARC, and USDA/ARS) were
maintained in DMEM supplemented with 10% FBS. PRRSV FL12 virus
stocks, an infectious clone derived highly virulent North American
strain (Kwon et al., 2006a,b; Truong et al., 2004), were prepared by
propagating and titrating the virus in MARC145 cells.
Preparation and phenotypic characterization of monocyte derived
macrophages
The procedure for the preparation of monocyte derived macro-
phages was followed as previously describedwith somemodiﬁcations
(Loving et al., 2007). Brieﬂy, peripheral blood mononuclear cells
(PBMCs) were isolated from heparinized blood by density gradientpromoter. Nsp1α downmodulates the activity of NF-κB at CRE-κB3 element of TNF-α
promoter. Nsp1β downmodulates the transactivation potential of Sp1 both at proximal
ion factor binding elements relative to transcription start site (+1). The diagram was
Tsai et al., 2000).
Table 1
Primers used in this study.
Primer name Primer sequence (5′ to 3′)a,b
pTNFa-F ATATATCCTAGGGCTCTTTTCTCTGAAATGCTGTCTGC
pTNFa-R ATATATAAGCTTGGGTCCTGGAGATGGCTTGTCT
pTNFa-194-F ATATATCCTAGGCTTCCAAACCGCCGCCCCCGCTAT
Nsp1-F ATATATCTCGAGATGTCTGGGATACTTGATCGG
FL12Nsp1a-R ATATATGCGGCCGCTTACATAGCACACTCAAAAGGGCA
FL12Nsp1b-F ATATATCTCGAGGCTGACGTCTATGATATTGGTCATG
Nsp1-R ATATATGCGGCCGCTTTACCGTACCATTTGTGACTGC
Gal4DBD147-F ATATATGCTAGCCACCATGAAGCTACTGTCTTCTATCGAACAAG
Gal4DBD147-R ATATATGGATCCCGATACAGTCAACTGTCTTTGAC
Sp1TAD-F ATATATGAATTCTATGAGCGACCAAGATCACTCCA
Sp1TAD-R ATATATGCGGCCGCTTATGAGGCTCTTCCCTCACTGTCTT
Sp1-N-F ATATATGAATTCTGGGGGCACAGGTGAACTTGAC
Sp1B-F ATATATGAATTCTATCACCTTGCTACCTGTCAACAGC
Sp1B-R ATATATGCGGCCGCTTACTGGATCCCTGAAGTACCCAATGC
Sp1Bc-F ATATATGAATTCTTCCGGACAGACCTTCACAACTC
a Restriction enzyme sites employed are underlined.
b Primer sequences for TNF-α, Nsp1, Sp1, Gal4 were designed utilizing the sequences
with NCBI accession numbers, NC_010449, AY545985, NM_013672.2 and NC_001148
respectively.
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Monocytes were enriched from PBMCs by glass adherence overnight
in DMEM supplemented with 10% FBS. Non-adherent lymphocyte
populations were removed by rigorous washing with PBS. Subse-
quently, the enriched adherent monocytes were incubated with
RPMI-1640 (Gibco) supplementedwith 10% FBS, 25 mMHEPES, 1 mM
sodium pyruvate, 1× non-essential aminoacids, 50 μg/mL gentamicin
(Sigma) and 5 ng/mL murine macrophage-colony stimulating factor
(M-CSF) for 7 days. After 7 days, differentiated macrophages were
harvested by using Hank's salt solution (HSS) based cell dissociation
buffer (Invitrogen). The cells were phenotypically characterized by
indirect ﬂow cytometry staining using the following mouse primary
antibodies such as anti-SWC3 mAb, anti-MHCII mAb (VMRD), anti-
CD163 mAb (Abserotec) and a goat anti-mouse IgG secondary
antibody conjugated with Alexaﬂuor 488 (Invitrogen). Staining with
secondary antibody only was used as negative control.
Quantitative PCR and ELISA for swine TNF-α
Monocyte derived macrophages were infected with PRRSV, FL12
strain, at MOI 10 or stimulated with LPS (1 μg/mL) for indicated time
points. Total RNAs were isolated from cells using Trizol LS reagent
(Invitrogen). 1–2 μg of total RNAs were reverse-transcribed using
MMLV-RT (invitrogen) and oligo-dT (Invitrogen) as primer. The
complementary DNAs (cDNAs) synthesized were used as template to
quantify the mRNA copy numbers for TNF-α and β-actin in samples by
quantitative PCR (qPCR) using speciﬁc primers and Taqman hydrolysis
probes. The following speciﬁc primers and probes were used in qPCR
reaction as previously described (with littlemodiﬁcations) (Kwon et al.,
2006b): For TNF-α: the forward primer is 5′ TCCAGTGGCAGAGTGGG-
TATG 3′ , the reverse primer is 5′ CCATCTGTCGGCACCACC 3′ and the
Taqman probe is 5′ AATGCCCTCCTGGCCAACGGC 3′. For β-actin: the
forward primer is 5′ CTCCTTCCTGGGCATGGA 3′, the reverse primer is 5′
CCACGTCGCACTTCATGATC and the Taqman probe is 5′ TGCGGCATC-
CACGAGACCACCT 3′. All primers and probes were custom synthesized
from Sigma-Genosys. The optimized concentrations of primers and
probeswere 300 nMeachprimer for TNF-α and 900 nMeach primer for
β-actin and 250 nM taqman probe for both TNF-α and β-actin. qPCR
was performed using Fast start PCR master mix (Roche Applied
sciences) and the reactions were run in Smartcycler (Cepheid). The
thermal proﬁle that was followed includes: 95 °C for 10 min (hot start)
followedby95 °C for 15 s (denaturation), 72 °C for60 s (extension) for a
total of 40 cycles. The mRNA copy numbers were calculated based on a
standard curve prepared using respective PCR product with calculated
copy numbers as template. The TNF-α mRNA copy numbers were
normalized with β-actin mRNA copy numbers which served as internal
control. The relative TNFa mRNA copy numbers (%) were calculated as
previously described (Stordeur et al., 2002). TNF-α protein levels in
supernatant were measured by using a commercial swine TNF-α
speciﬁc ELISA (Pierce) as per manufacturer's instructions.
Plasmids construction
pGL3-Basic and pGL4.32NFkBRE-luc were purchased from Promega.
pswTNF-α-luc plasmid was constructed by cloning swine TNF-α
promoter sequences (−1348 to +58, position +1 refers to transcrip-
tion start site of TNF-α gene, NCBI accession No: NC_010449) into pGL3
basic vector (Promega). pswTNFa-194 luc was constructed by cloning
−194 to +58 region of TNF-α promoter into pGL3-Basic vector. All
plasmids expressing non-structural proteins of PRRSV were described
previously (Beura et al., 2009). Plasmids expressing exact sequences of
Nsp1α and Nsp1βwere constructed by cloning nt 192–731 and nt 732–
1340 sequences of FL12 (Genbank accession no: AY545985) into CMV
based expression vector, pIHA-FLAG, which was described previously
(Beura et al., 2009). The expression of these constructs was conﬁrmed
by Western blot using rabbit polyclonal antibody custom developedagainst PRRSV-FL12 Nsp1 (Open Biosystems). TF-speciﬁc reporter
plasmids were constructed by cloning sequences of 3X Sp1/Egr1RE or
3X CRE-kB3 RE or 5X Sp1RE fragments (indicated in Fig. 3A, whose
sequences were derived from swine TNF-α promoter) into pGL4.32
vector (Promega) by replacing 5×NF-κB RE fragment betweenNheI and
BglII cloning sites.GAL4-Sp1TADexpressingplasmidwas constructedby
cloning the transactivation region (1–615 aminoacids) of Sp1 (GenBank
Accession No: NM_013672.2) fused in framewith DNA binding domain
(1–147 amino acids) of Gal4 (GenBank Accession No: NC_001148) into
amammalian expression vector, pCDNA3.1+ (Invitrogen). Gal4-Sp1-N,
Gal4-Sp1B and Gal4-Sp1Bc were constructed by cloning 90–615, 263–
542, and 421–542 amino acid sequences of Sp1 respectively in frame
with Gal4 DNA binding domain into pCDNA3.1+ vector. Sequences of
all primers used for PCR amplication were indicated in Table 1. The 5×
Gal4RE-luc was constructed by cloning ﬁve tandem repeats of Gal4
responsive element using the following sequence derived from natural
Gal10 promoter sequence of Saccharomyces cerevisiae (GenBank acces-
sion no: NC_001134), 5′ ACGGAGGAGAGTCTTCCGTCGGAGGGCTGT-
CGCCCGCTCGGCGGCTTCTAATCCGT 3′ (underlined sequences correspond
to Gal4 binding elements) into pGL4.32 vector by replacing NF κB RE
element as described above.
RAW cell transfection and luciferase reporter assays
RAW 264.7 cells were transfected with all plasmids using DEAE-
dextran chemical transfection by a procedure that has been slightly
modiﬁed from a previous report (Escher et al., 2005). Brieﬂy, 2.0×105
cells /mLwere plated in a 12well plate one day before transfection. Just
before transfection, cells were washed once with serum free RPMI
medium. Then, cells were incubated for 2 h with 1 mL of transfection
cocktail prepared with serum free RPMI medium that contains 50 mM
Tris-Cl, pH7.4, 1.6 mg of DEAE-dextran (Sigma) and required amount of
plasmid DNAs. After 2 h incubation at 37 °C, cells were washed twice
with serum free RPMI medium followed by 10 % DMSO (prepared in
PBS) shock for 1 min. Then, cells were washed again two times with
serum free RPMI medium before adding the growth medium. For
western blotting, ﬁnal growth medium was supplemented with 0.5 μM
5-azacytidine to increase the transfection efﬁciency as described
previously (Escher et al., 2005). For luciferase reporter assays, cells
were transfected with PRRSV protein expressing plasmids along with
relevant ﬁreﬂy reporter plasmid (200 ng), pRL-TK (Promega) renilla
vector (10 ng) and further incubated for 24 h at 37 °C to facilitate
protein expression. After 24 h of incubation, transfected RAW cells were
stimulated with LPS (Sigma) (ﬁnal concentration, 1 μg/mL) for 6 h to
stimulate the promoter. Cells were then lysed and luciferase activities
278 S. Subramaniam et al. / Virology 406 (2010) 270–279were measured in GloMax 20/20 luminometer (Promega) using dual
luciferase assay kit (Promega) as per manufacturer's instructions.
Fireﬂy luciferase activities in stimulated cells were expressed as
luciferase units relative to unstimulated cells after normalizing the
transfection efﬁciency with renilla luciferase values.Acknowledgments
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